Publications (45) FRANCISCO JAVIER CARRIÓN HERRERO publications

2024

  1. Solid Lipid Nanoparticles Enhancing the Leishmanicidal Activity of Delamanid

    Pharmaceutics, Vol. 16, Núm. 1

2023

  1. A Tailored Approach to Leishmaniases Vaccination: Comparative Evaluation of the Efficacy and Cross-Protection Capacity of DNA vs. Peptide-Based Vaccines in a Murine Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  2. Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease

    Pathogens, Vol. 12, Núm. 7

2022

  1. Transcriptomic Profile of Canine DH82 Macrophages Infected by Leishmania infantum Promastigotes with Different Virulence Behavior

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

2021

  1. Properties of virulence emergence of Leishmania infantum isolates from Phlebotomus perniciosus collected during the human leishmaniosis outbreak in Madrid, Spain. Hepatic histopathology and immunological parameters as virulence markers in the mouse model

    Transboundary and Emerging Diseases, Vol. 68, Núm. 2, pp. 704-714

  2. Raccoons (Procyon lotor) in the Madrid region of Spain are carriers of antimicrobial-resistant Escherichia coli and enteropathogenic E. coli

    Zoonoses and Public Health, Vol. 68, Núm. 2, pp. 69-78

2020

  1. A further investigation of the leishmaniosis outbreak in Madrid (Spain): low-infectivity phenotype of the Leishmania infantum BOS1FL1 isolate to establish infection in canine cells

    Veterinary Immunology and Immunopathology, Vol. 230

  2. Epitope selection for fighting visceral leishmaniosis: Not all peptides function the same way

    Vaccines, Vol. 8, Núm. 3

2019

  1. Immunization with the hisAK70 DNA vaccine induces resistance against leishmania amazonensis infection in BALB/c mice

    Vaccines, Vol. 7, Núm. 4

  2. PLGA cationic nanoparticles, obtained from nano-emulsion templating, as potential DNA vaccines

    European Polymer Journal, Vol. 120

  3. Strength and medium-term impact of HisAK70 immunization in dogs: Vaccine safety and biomarkers of effectiveness for ex vivo Leishmania infantum infection

    Comparative Immunology, Microbiology and Infectious Diseases, Vol. 65, pp. 137-143

2017

  1. Alternative strategy for visceral leishmaniosis control: HisAK70-Salmonella Choleraesuis-pulsed dendritic cells

    Comparative Immunology, Microbiology and Infectious Diseases, Vol. 54, pp. 13-19

  2. Ruminants are not a reservoir of enteroaggregative Escherichia coli

    Austral journal of veterinary sciences, Vol. 49, Núm. 1, pp. 25-26

  3. Short communication: Isolation frequency of bacteria causing lymphadenitis and abscesses in small ruminants in central Spain

    Small Ruminant Research, Vol. 154, pp. 5-8

2016

  1. Engineering of a live Salmonella enterica serovar Choleraesuis negative-marker strain that allows serological differentiation between immunised and infected animals

    Veterinary Journal, Vol. 213, pp. 53-58

  2. Subtilase cytotoxin-encoding subAB2 variants in verotoxin-producing Escherichia coli strains isolated from goats and sheep

    Research in Veterinary Science, Vol. 105, pp. 74-76

2015

  1. HisAK70: Progress towards a vaccine against different forms of leishmaniosis

    Parasites and Vectors, Vol. 8, Núm. 1

2014

  1. Characterisation of the ex vivo virulence of Leishmania infantum isolates from Phlebotomus perniciosus from an outbreak of human leishmaniosis in Madrid, Spain

    Parasites and Vectors, Vol. 7, Núm. 1

2013

  1. Differences in virulence gene expression between atypical enteropathogenic Escherichia coli strains isolated from diarrheic and healthy ruminants

    Canadian Journal of Veterinary Research, Vol. 77, Núm. 2, pp. 158-160

  2. UCP2 Deficiency Helps to Restrict the Pathogenesis of Experimental Cutaneous and Visceral Leishmaniosis in Mice

    PLoS Neglected Tropical Diseases, Vol. 7, Núm. 2